Tag: orphan drug protection

Orphan Drug Exclusivity: How Rare-Disease Medicines Get Market Protection

Orphan Drug Exclusivity: How Rare-Disease Medicines Get Market Protection

Orphan drug exclusivity gives pharmaceutical companies seven years of market protection for rare disease treatments, encouraging development of drugs that would otherwise be unprofitable. Here's how it works, who benefits, and why it's changing.